Antibe Therapeutics

(ATBPF)

By |

Profile

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 570-5103
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Antibe Therapeutics Inc is a healthcare company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen. The company has two primary business segments: Antibe Therapeutics, a pharmaceutical development company, and Citagenix, a marketer and distributor of regenerative medicines serving the dental and orthopedic marketplaces.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 570-5103
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQB
CEO: Daniel Legault
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.26 $ -0.0098 (-3.63%)
Last Price 0.26 Change $ -0.0098 Change % -3.63 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.26 High 0.26 Low 0.26 Prev Close 0.27
Last Trade Volume 15,000 52 Wk Hi 0.43 52 Wk Low 0.18
Market Cap 63.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 243,905,811.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB